Ovarian Cysts In Women Research Articles

O667 Audit of management referral for ovarian cyst in women (above 50 yrs)

International Journal of Gynecology & ObstetricsVolume 107, Issue S2 p. S284-S284 Free communication (oral) presentations O667 Audit of management referral for ovarian cyst in women (above 50 yrs) K. Nayini, Search for more papers by this authorM. Vachhani, Search for more papers by this authorS. Singh, Search for more papers by this authorP. Sarkar, Search for more papers by this author K. Nayini, Search for more papers by this authorM. Vachhani, Search for more papers by this authorS. Singh, Search for more papers by this authorP. Sarkar, Search for more papers by this author First published: 06 October 2011 https://doi.org/10.1016/S0020-7292(09)61040-7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume107, IssueS2Abstracts of XIX FIGO World Congress of Gynecology and ObstetricsOctober 2009Pages S284-S284 RelatedInformation

OC155: Management of complex ovarian cysts in women with post‐menopausal bleeding

OC155: Management of complex ovarian cysts in women with post‐menopausal bleeding

25: Retrospective Analysis of 25 Borderline Ovarian Cysts in Women of Reproductive Age. Our Experience Compared to Literature Findings

To assess the best treatment recommended for borderline ovarian cyst in women of reproductive age group, the consequences on their fertility and the different treatments available in case of infertility after treatment. Retrospective analysis of 25 women treated for borderline ovarian cyst. Comparison of our experience with information from literature review. University hospital in Strasbourg. Twenty-five consecutive women younger than 42 years presented for therapeutic decisions during our multidisciplinary meeting for gynecologic cancers between January 1990 and December 2003. Forty-eight percent of the patients (mean age 26.9 years) had fertility sparing treatment (12/25) including 9 laparotomies and 3 laparoscopies. 52% (mean age 38,4 years) had radical treatment (13/25) including 12 laparotomies and one vaginal surgery laparoscopically assisted. Recurrence rate in conservative treatment was 8.3% (mean follow-up of 6.6 years) versus 0% in case of radical treatment (mean follow-up of 3.8 years). There was no death immediately related to the borderline ovarian cyst. Before surgery, only 48% of the patients had no infertility problem, 16% suffered from primary or secondary infertility. After treatment 33% desired pregnancy and 75% of them became pregnant. There were 6 pregnancies in a mean follow-up of 3 years. One pregnancy was obtained by IVF. This patient presented with recurrence. Conservative treatment with complete resection is reasonable in women who want preserve childbearing function, if there are no invasive implants or pseudomyxoma peritonalis. Conservative treatment is associated to a higher recurrence rate but this does not seem to affect survival, if subsequent surveillance of these patients is done. Induction of ovulation does not seem affect survival of these patients. It can be done in properly selected patients with restriction of the number of stimulation cycles. These results plea for a larger use of the laparoscope in this population of women desiring pregnancy.

Diagnosis and management of simple ovarian cysts

Adnexal masses are found in 6% of women of reproductive age. Ultrasonography can clearly identify the characteristics of ovarian cysts. Simple ovarian cysts in women of reproductive age have commonly been treated with oral contraceptives. However expectant management can also be effective. The present study evaluates the results of expectant management of simple ovarian cysts and compares these results with those of oral contraceptive treatment. This randomized controlled trial of a 24-months duration enrolled 141 premenopausal women younger than 50 years who had low serum cancer antigen (CA)-125 levels (< 65 U/mL) and an ovarian cyst detected by transvaginal Doppler ultrasonography within the first 5 days of their menstrual cycle. The women were assigned to expectant management (n = 74 group 1) or to receive daily hormonal treatment (n = 67 group 2). The treatment consisted of 20 µg of ethinyl estradiol and 150 µg of desogestrel (Myralon; Organon Ilac AS Istanbul Turkey). (excerpt)

Natural Plants Treatment for Ovarian Cysts in Women Without Surgery

Women normally have two ovaries as part of their reproductive organs. The ovaries function by secreting the important reproductive hormone—estrogen which regulate the monthly menstrual cycle at puberty. Each ovary also produce the eggs that carry the female gametes required to fuse with the male sperm cells in the formation of foetus. One of the abnormalities of the ovaries that had been long recognized is the development of sacs with membranous wall enclosing fluid, semi-solid matter or altered blood described as ovarian cyst which alter the size of the ovaries and make them larger. This abnormality usually disorganize the regular monthly cycles along with other complications including pains and infertility in women. The causes for the development of ovarian cysts are not clearly understood while surgical operation had been the most popular method of treatment. There is ethno-medicinal evidence for the treatment of ovarian cysts in Nigeria which dates back to more than one hundred years This paper describes how 274 of clinically confirmed cases of ovarian cysts in women between the ages of 22-52 years were treated successfully without surgery at the NARL specialist clinic, Ibadan, Nigeria in the last 16 years (1988-2004) using natural plant medicines made with the fiber of Cocos nucifera and a few other tropical plants. The implications of this finding are discussed.

Clinical Management of Functional Ovarian Cysts: A Prospective and Randomized Study

Most ovarian cysts in women of reproductive age are physiological (functional) and patients have been treated for years with oral contraceptives to obtain the resolution of these cysts. Expectant management has been suggested to have the same effectiveness as hormonal treatment but such suggestions come from studies including all kinds of cysts. The objective of the present study was to assess the resolution of functional ovarian cysts, observed after ovulation induction, with expectant management and hormonal treatment and also to determine the period of time necessary for the resolution of the cysts. For this purpose, 53 patients with ovarian cysts, observed by transvaginal ultrasound within the first 5 days of a cycle after ovulation induction, were randomized to have expectant management (group A) or to receive oral contraception (group B) for one cycle. If the cyst persisted, the patient was followed for another cycle, without any treatment. Within the 50 women who completed the trial, a complete resolution of the cysts was observed in 19/25 (76%) and 18/25 (72%) in groups A and B respectively. On the other hand, all the persistent cysts disappeared after a second cycle without any treatment. In conclusion, expectant management is as effective as oral contraceptives for the resolution of functional ovarian cysts induced by ovarian stimulation. However, studies with a larger number of cases are needed to increase the power of the results and to obtain a firm conclusion.

Clinical management of functional ovarian cysts: a prospective and randomized study

Most ovarian cysts in women of reproductive age are physiological (functional) and patients have been treated for years with oral contraceptives to obtain the resolution of these cysts. Expectant management has been suggested to have the same effectiveness as hormonal treatment but such suggestions come from studies including all kinds of cysts. The objective of the present study was to assess the resolution of functional ovarian cysts, observed after ovulation induction, with expectant management and hormonal treatment and also to determine the period of time necessary for the resolution of the cysts. For this purpose, 53 patients with ovarian cysts, observed by transvaginal ultrasound within the first 5 days of a cycle after ovulation induction, were randomized to have expectant management (group A) or to receive oral contraception (group B) for one cycle. If the cyst persisted, the patient was followed for another cycle, without any treatment. Within the 50 women who completed the trial, a complete resolution of the cysts was observed in 19/25 (76%) and 18/25 (72%) in groups A and B respectively. On the other hand, all the persistent cysts disappeared after a second cycle without any treatment. In conclusion, expectant management is as effective as oral contraceptives for the resolution of functional ovarian cysts induced by ovarian stimulation. However, studies with a larger number of cases are needed to increase the power of the results and to obtain a firm conclusion.

Laparoscopic approach to ovarian cysts in women over 40 years of age.

Laparoscopic approach to ovarian cysts in women over 40 years of age.

Ovarian cysts in women receiving tamoxifen for breast cancer.

Tamoxifen is a nonsteroidal anti-oestrogen with gynaecological side-effects. Only recently, ovarian cyst formation during tamoxifen treatment has been reported. The present study aimed to evaluate patient-related parameters that determine ovarian cyst formation in women using tamoxifen for breast cancer. A cross-sectional study was performed in 142 breast cancer patients using tamoxifen. Forty-five patients were also examined prior to tamoxifen treatment. Gynaecological assessment, transvaginal ultrasonography (TVU) and serum oestradiol (E2) and follicle stimulating hormone (FSH) analysis were performed. Follow-up assessments were performed twice a year. Uni- or bilateral ovarian cysts were detected by TVU in 24 tamoxifen-using patients and in one patient before tamoxifen treatment. Multiple regression analysis showed that cyst development is related (multiple R = 0.73) to high E2 (P < 0.001), younger age (P < 0.001) and absence of high-dose chemotherapy (P = 0.007). Patients with ovarian cysts had higher serum E2 levels compared to patients without cysts (1.95 vs 0.05 nmol l−1; P < 0.001). All patients after high-dose chemotherapy or older than 50 years had E2 < 0.10 nmol l−1 and/or amenorrhoea > 1 year and did not develop ovarian cysts. Patients still having a menstrual cycle during tamoxifen had a high chance (81%) of developing ovarian cysts. Breast cancer patients receiving tamoxifen only develop ovarian cysts if their ovaries are able to respond to FSH stimulation as shown by E2 production. © 1999 Cancer Research Campaign

Laparoscopic vs. laparotomic ovarian cystectomy in reproductive age women: an economic evaluation

ObjectiveThis study was carried out to assess both the efficacy and the economic advantages of two different surgical techniques in the treatment of ovarian cysts in women of reproductive age.DesignA prospective randomized clinical study.SettingEndocrinological Gynaecology Department of the Catholic University of S. Cuore, Rome.SubjectsThese were 68 women of reproductive age (16–39 years) who were hospitalized for ovarian cysts which had persisted for at least 3 months, or who were noted to have an increase in ovarian volume detected by consecutive ultrasound investigations.InterventionsOf these patients, 34 received laparotomic treatment using a Pfannewstiel incision and traditional techniques. The other 34 patients underwent a laparoscopic stripping of the capsule of the cyst with no sutures on the ovary.ResultsThe two techniques showed similar levels of safety and efficacy. The comparison of direct and indirect costs for the two procedures showed an average total cost of $4940 for laparotomic surgery and $3543 for laparoscopy.ConclusionsThe present study demonstrates that ovarian cysts can be as well treated using laparoscopic access as with laparotomy, but with an average cost reduction of 28% for the former.

Laparoscopic treatment of ovarian cysts in women under 40 years of age

Laparoscopic treatment of ovarian cysts in women under 40 years of age

Ovarian cyst aspiration: a therapeutic approach to ovarian hyperstimulation syndrome

Ultrasonographically guided transvaginal aspiration of ovarian cysts in women with severe OHSS after GIFT or IVF was safe and has resulted in immediate relief of symptoms, a shorter disease process, and outpatient treatment. The patients were allowed to go back to normal activity after the procedure. The progression of the disease was interrupted and six of seven patients carried beyond 20 weeks' gestation.

Ovarian cysts in women with inflammatory bowel disease.

The frequency of ovarian cysts in patients with Crohn's disease (CD) or ulcerative colitis (UC) is believed to be higher than in the normal population, but this aspect has not been studied hitherto. The prevalence of ovarian cysts in the normal population is unknown. By ultrasonic scanning, we studied the frequency of ovarian cysts in 61 patients with CD, 64 with UC, and in 100 controls. The findings were positive in 3 out of 61 with CD, 5 of 64 with UC, and in 2 of 100 controls. There is a tendency to a higher frequency of ovarian cysts in patients with inflammatory bowel diseases than in the normal population, but no statistically significant difference.

Ovarian cyst fenestration via the laparoscope. A laparoscopic method for treatment of non-neoplastic ovarian cysts.

A laparoscopic method of managing macroscopically benign, unilateral, unilocular, mobile, translucent, and smooth-walled ovarian cysts in women of reproductive age is described. The method requires the cutting of a window in the cyst wall through the laparoscope fenestration. In preference to aspiration at laparoscopy or removal at laparotomy, this method has the advantage of ensuring histologic material as well as permanent drainage by the use of atraumatic surgical technique. Nineteen cysts were fenestrated laparoscopically. Four cysts could not be classified, two owing to lack of histologic material, two owing to malpreparation of the selected cyst tissue. In one case an epithelial cyst--a mucinous cystadenoma, being laparoscopically unsuspected--was fenestrated. One cyst recurred. By observing the above criteria it is possible and tolerably safe to select non-neoplastic cysts, for which fenestration should be reserved.

Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception.

Asymptomatic volunteer women with a regular pattern of uterine bleeding and using the progestogen-only oral contraceptive pill were compared with control women who were not exposed to hormones. Pelvic ultrasound scanning at the end of the next bleeding episode after recruitment demonstrated functional cysts with maximum diameters ranging between 30 and 58 mm in eight of the 21 pill users, four of whom also had palpable ovaries, three cysts regressed during the next cycle. Of the 13 women with normal ovaries initially, four developed a new functional cyst of which two were associated with pain. Of the 12 women with cysts seven complained of pain at some time during the monitored cycle. Among 21 control women only one symptom-free (42 mm) cyst was shown on the initial postmenstrual ultrasound scan and this resolved painlessly during the scanned cycle with ovulation from the opposite ovary. Ovulation was also demonstrated in 16 of the remainder; but in none of the three control women who developed asymptomatic functional cysts (35-47 mm in size) while under observation. Since 11 of the 14 pill-users who failed to ovulate also had a functional cyst, the contraceptive efficacy may depend in part on this association. Pain symptoms may make the method less acceptable and give rise to diagnostic problems and inappropriate therapies.